Latest Mergers & Acquisitions and Divestments - Healthcare Sector

Get timely intelligence about mergers & acquisitions (M&A) and divestments in the healthcare sector. Maximize Revenue, Minimize Risk.

Start a Free Trial Schedule A Call

Recent Mergers & Acquisitions (M&A) Deals Data in Healthcare 

Ajinomoto acquires Forge Biologics for $620 million

Deal Size: $620 Million

Announced Date:  November 2023

Ajinomoto Co. has acquired Forge Biologics, a leading manufacturer of genetic medicines, in an all-cash deal for $620 million.

CooperCompanies has acquired reproductive health products from Cook Medical after a failed takeover

Deal Size: $300 Million

Announced Date: November 2023

CooperCompanies has acquired certain medical device assets, focused primarily on Doppler monitoring, obstetrics, and gynecology surgery markets, from Cook Medical for approximately $300m.

LimFlow announces agreement to be acquired by Inari Medical

Deal Size: $415 Million

Announced Date: November 2023

LimFlow SA, a pioneer in developing minimally invasive technology, has been acquired by Inari Medical, a medical device company, for $415 million.

Healthwell Acquisition Corp. I terminates business combination with Starton Therapeutics

Deal Size: ND

Announced Date:  November 2023

Healthwell Acquisition Corp. I has terminated its business combination with Starton Therapeutics. The conditions to the closing of the initial business combination were not satisfied or waived by the outside date of November 3, 2023. As a result, Healthwell will seek an alternative business combination.

Standard BioTools and SomaLogic to Merge, Creating a Diversified Leader in Life Sciences Tools 

Deal Size: $1 Billion

Announced Date:  October 2023

Standard BioTools, driven by a bold purpose of unleashing tools to accelerate breakthroughs in human health – and SomaLogic, a leader in data-driven proteomics technology, have entered into a definitive agreement to combine in an all-stock merger. The combined company, with a pro-forma equity value of over $1 billion

How can you benefit from the Intellizence Mergers & Acquisitions (M&A) Dataset?

Identify Prospective Customers:

Intellizence M&A dataset provides valuable insights into healthcare companies that have recently undergone Mergers or Acquisitions. This information allows sales teams to identify potential healthcare customers who may need new products or services, are experiencing organizational changes, or are looking to expand their operations. 

Expand Cross-Selling and Upselling Opportunities:

Intellizence M&A dataset enables sales, account management, and customer success teams to identify cross-selling and upselling opportunities within their existing customer base in healthcare. By analyzing the acquisitions or divestments in their healthcare customers, they can uncover areas where additional products or services may be required and ultimately drive increased revenue from existing accounts.

Investment and Trading:

The Intellizence M&A dataset serves as a goldmine for investors and financial analysts. By analyzing historical M&A transactions in the healthcare industry, investment teams can identify trends and industry dynamics, assess market sentiment, and make better investment strategies.  

Corporate Development and Strategy:

By analyzing the Intellizence M&A dataset, corporate development and strategy professionals can better understand consolidation, emerging market trends, and competitive dynamics in the healthcare sector. This knowledge helps evaluate market gaps, identify strategic alliances, and devise plans to expand market share and diversify offerings.

Competitive Intelligence:

Intellizence M&A dataset offers timely intelligence about corporate mergers & acquisitions, divestments, and spinoffs in healthcare. By tracking these events, sales and competitive intelligence teams can gain insights into their competitors’ strategies, identify potential vulnerabilities, and differentiate themselves in the market. 

Why Subscribe to Intellizence Mergers & Acquisitions (M&A) Dataset?

AI-Powered Platform:

The Intellizence company intelligence platform is powered by cutting-edge Natural Language Processing and Machine Learning technologies that curate M&A data from multiple external sources. Every record is human-audited for data integrity.

Delivered in Near Real-time:

Intellizence monitors thousands of sources in real-time for any latest M&A announcements from various unstructured external sources and delivers merger & acquisition data in a structured format.

Comprehensive Coverage:

Intellizence curates the data from news sources, including <industry name> focused news sites, press wires, and regulatory filings to ensure comprehensive coverage. The intellizence M&A dataset covers data from healthcare and all other emerging and established industries.

Multiple Delivery Channels:

The M&A news is delivered through multiple channels – Web Platform, Email Alerts, Slack, CRM, and ChatGPT Plugin. We offer API to power your applications and models with real-time merger & acquisition news and data. 

One-Stop Data Provider for Company Signals:

In addition to Merger & Acquisition News & Data, Intellizence offers curated news on 80+ company signals and structured datasets – Startup Funding, Mergers & Acquisitions, Business Expansion, Major Hiring, CXO Appointments & Changes, and Data & Security Breaches.

More about Intellizence M&A Dataset

Subscribe to Intellizence to get the latest intelligence about healthcare companies for sales intelligence, competitive intelligence, customer intelligence, market intelligence, and risk intelligence activities.

Latest Mergers & Acquisitions (M&A) Data – Explore Other Industries

Subscribe to Intellizence